Stay updated with breaking news from Kimberly Workowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
William L. Jeffries IV tracks the health effects of race and disease outbreaks for a living at the U.S. CDC. But even he couldn’t have foreseen what would happen when he contracted monkeypox himself.
It took three doctor visits -- and a desperate call to a colleague -- for a Black scientist to get treatment.
As a Black man and a senior CDC scientist, William L. Jeffries IV knows a lot about health inequities and infectious diseases in America. Still, it took...
"I emphasize my training and my experience because if I had to go to three different places before I got diagnosed, imagine what the average gay man has to do?"
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI 98% of Treatment-Naïve Patients Achieved and Maintained Undetectable Viral Load with Biktarvy Through Four Years in the Open-Label Extension Phase of Two Phase 3 Studies – – Treatment-Naïve Adults Reached and Maintained Undetectable Viral Load with Biktarvy for Certain Transmitted-Drug Resistance and with No Treatment-Emergent Resistance Through 144 Weeks – Gilead Sciences, Inc. today announced new, … >98% of Treatment-Naïve Patients Achieved and Mainta...